Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on August 3, 2026

Aug. 3, 2026

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

Indeterminate GlobeNewswire

Aug. 3, 2026

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 3, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

Indeterminate GlobeNewswire

Aug. 3, 2026

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

Indeterminate GlobeNewswire

Aug. 3, 2026

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Indeterminate GlobeNewswire

Aug. 3, 2026

argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Keros Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

Indeterminate GlobeNewswire

Aug. 3, 2026

REACT19 Launches $100,000 Matching Campaign as Demand for Medical Grants Surges 33%

Indeterminate GlobeNewswire

Aug. 3, 2026

Randomized U.S. Trial Finds Autonomous System Improves Precision of Hospital Oxygen Therapy

Indeterminate GlobeNewswire

Aug. 3, 2026

A Race Against Blindness Launches New Research Grants Program to Accelerate Treatments for Inherited Retinal Diseases and Bardet-Biedl Syndrome

Indeterminate GlobeNewswire

Aug. 3, 2026

Dental Tourism Surges in 2026: DentaVacation Reports on Market Trends and Top Destinations

Indeterminate EIN Presswire